Expression and significance of HER family receptors in neuroblastic tumors

Clinical and Experimental Metastasis

Volumn 28, Issue 3, 2011, Pages 271-282

  Izycka Swieszewska, Ewa ^a   Wozniak, Agnieszka ^a,b   Drozynska, Elzbieta ^a   Kot, Jacek ^a   Grajkowska, Wieslawa ^c   Klepacka, Teresa ^d   Perek, Danuta ^c   Koltan, Sylwia ^e   Bien, Ewa ^a   Limon, Janusz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^d INSTITUTE OF MOTHER AND CHILD   (Poland)

^e NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

EGFR; FISH; HER2; HER3; HER4; Immunophenotype; Neuroblastoma; Prognostic factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4;

ADOLESCENT; ARTICLE; CELL DIFFERENTIATION; CHILD; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; NERVOUS SYSTEM TUMOR; NEUROBLAST; NEUROBLASTIC TUMOR; NEUROBLASTOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; SCORING SYSTEM; TUMOR LOCALIZATION; CANCER STAGING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOPHENOTYPING; INFANT; METABOLISM; MORTALITY; NEWBORN; PATHOLOGY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPHENOTYPING; INFANT; INFANT, NEWBORN; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3;

EID: 79953299753     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-010-9369-1     Document Type: Article

References (37)

1. Brodeur G (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203-216 (Pubitemid 37328872)
2. Maris J, Hogarty M, Bagatell R, Cohn S (2007) Neuroblastoma. Lancet 369:2106-2120 (Pubitemid 46935947)
3. Nakagawara A (2004) Neural crest development and neuroblastoma: the genetic and biological link. Prog Brain Res 146: 233-242 (Pubitemid 37541386)
4. Mosse YP, Laudenslager M, Longo L, Maris J (2008) Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455:930-935
5. Shimada H, Ambros I, Dehner L et al (1999) The international neuroblastoma pathology classification (the Shimada system). Cancer 86:364-372 (Pubitemid 29327594)
6. Joshi W, Silverman J, Altshuler G et al (1993) Systematization of primary histopathologic and fine-needle aspiration cytologic features and description of unusual histopathologic feature of neuroblastic tumors: a report from the Pediatric Oncology Group. Hum Pathol 24:493-504 (Pubitemid 23145801)
7. Cohn S, Pearson A, London W et al (2009) The international neuroblastoma risk group (INRG) classification system: an INRG task force report. J Clin Oncol 27:289-297
8. Fong A, Park J (2009) High-risk neuroblastoma: a therapy in evolution. Pediatr Hematol Oncol 26:539-548
9. Jakacki R, Hamilton M, Gilbertson R et al (2008) Pediatric phase I and pharmacokinetic study of Erlotinib followed by the combination of Erlotinib and Temozolomid: a children's oncology group phase I consortium study. J Clin Oncol 26:4921-4927
10. Vermuelen J, De Preter K, Naranjo A et al (2009) Predicting outcomes for children with neuroblastoma using a multigene expression signature: a retrospective SIOPEN/COG/GPOH study. Lancet Oncol 10:663-671
11. Baselga J, Swain S (2009) Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 9:463-475
12. Citri A, Yarden Y (2006) EGF-ERBB signaling: towards the systems level. Nat Rev Mol Cell Biol 7:505-516 (Pubitemid 44036456)
13. Zaczek A, Brandt B, Bielawski KP (2005) The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches. Histol Histopathol 20:1005-1015 (Pubitemid 40932618)
14. Britsch S, Li L, Kirchhoff S et al (1998) The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system. Genes Dev 12: 1825-1836 (Pubitemid 28304335)
15. Casalini P, Iorio M, Galmozzi E, Menard S (2004) Role of HER receptors family in development and differentiation. J Cell Physiol 200:343-350 (Pubitemid 39006925)
16. Chan R, Hardy W, Laing M, Hardy S, Muller W (2002) The catalytic activity of the ErbB2 receptor tyrosine kinase is essential for embryonic development. Mol Cell Biol 22:1073-1078 (Pubitemid 34094844)
17. Ganti R, Skapek S, Zhang J et al (2006) Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma. Modern Pathol 19:1213-1220 (Pubitemid 44268191)
18. Ho R, Minturn J, Hishiki T et al (2005) Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor. Cancer Res 65:9868-9875 (Pubitemid 41541466)
19. Richards KN, Zweidler-McKay PA, Van Roy N et al (2010) Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo. Cancer 116:3233-3243
20. Qualman S, Bowen J, Fitzgibbons P et al (2005) Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumors. Arch Pathol Lab Med 129:874-883 (Pubitemid 40934306)
21. Izycka-Swieszewska E, Wozniak A, Kot J et al (2010) Prognostic significance of HER2 expression in neuroblastic tumors. Mod Pathol 23:1261-1268
22. Corzo C, Bellosillo B, Corominas J et al (2007) Does polysomy of chromosome 17 have a role in ERBB2 and topoisomerase IIα expression. Tumor Biol 28:221-228
23. Varella-Garcia M (2006) Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay. Diagn Pathol 1:19
24. Vandensompele J, Baudis M, De Preter K et al (2005) Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma. J Clin Oncol 23:2280-2299 (Pubitemid 46218721)
25. Gilbertson RJ (2005) ERBB2 in pediatric cancer: innocent until proven guilty. Oncologist 10:508-517 (Pubitemid 41266332)
26. Rogers S, Harrington K, Rhys-Evans P et al (2005) Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev 24:47-69 (Pubitemid 40576063)
27. Layfield L, Thompson K, Dodge R, Kerns B (1995) Prognostic indicators for neuroblastoma: stage, grade, DNA ploidy, MIB-1-proliferation index, p53, HER-2/neu and EGFR-a survival study. J Surg Oncol 59:21-27
28. Tamura S, Hosoi H, Kuwahara Y et al (2007) Induction of apoptosis by an inhibitor of EGFR in neuroblastoma cells. BBRC 358:226-232 (Pubitemid 46719107)
29. Rossler J, Odenthal E, Geoerger B et al (2009) EGFR inhibition using Gefitinib is not active in neuroblastoma cell lines. Anticancer Res 29:1327-1334
30. Chiu B, Mirkin B, Madonna M (2007) Epidermal growth factor can induce apoptosis in neuroblastoma. Mitogenic and apoptotic actions of EGF on neuroblastoma cells are concentrationdependent. J Ped Surg 42:482-488
31. Tovey S, Reeves J, Stanton P, Ozanne B, Barlett J, Cooke T (2006) Low expression of HER2 protein in breast cancer is biologically significant. J Pathol 210:358-362 (Pubitemid 44660515)
32. Goji J, Nakamura H, Ito H, Mabuchi O, Hashimoto K, Sano K (1995) Expression of c-ErbB2 in human neuroblastoma tissues, adrenal medulla adjacent to tumor, and developing mouse neural crest cells. Am J Pathol 146:660-672
33. Gambini C, Sementa AR, Boni L et al (2003) Expression of HER2/neu is uncommon in human neuroblastic tumors and is unrelated to tumor progression. Cancer Immunol Immunother 52:116-120 (Pubitemid 36337619)
34. Hayashi M, Inokuchi M, Takagi Y et al (2008) High expression of HER3 is associated with a decreased survival in gastric cancer. Clin Cancer Res 14:7843-7849
35. Witton C, Reeves J, Going J, Cooke T, Barlett J (2003) Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer. J Pathol 200:290-297 (Pubitemid 36827302)
36. Srinivasan R, Poulsom R, Hurst H, Gullick W (1998) Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumor types. J Pathol 185:236-245 (Pubitemid 28320044)
37. Muraoka-Cook R, Sandahl M, Husted C et al (2006) The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells. Mol Biol Cell 17:4118-4129 (Pubitemid 44330893)